Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Other Non-Current Liabilities (2025)

Valion Bio has reported Other Non-Current Liabilities over the past 1 years, most recently at $48000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $48000.0; the TTM value through Dec 2025 reached $48000.0, changed N/A, while the annual FY2025 figure was $48000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $48000.0 at Valion Bio.
  • Over five years, Other Non-Current Liabilities peaked at $48000.0 in Q4 2025 and troughed at $48000.0 in Q4 2025.